State to seek DCGI inspection of Maiden Pharma s premises tribuneindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tribuneindia.com Daily Mail and Mail on Sunday newspapers.
As no action has been initiated against Maiden Pharmaceuticals in India over the four “contaminated” baby syrups due to a delay in the lab test reports, the Ministry of Health, Gambia, has put out an acute kidney injury (AKI) update, specifying that there were 82 confirmed cases, of whic
Sonepat-based Maiden Pharmaceuticals had exported 50,000 units of four cough syrups to Gambia, of which 41,000 have been recalled so far. However, over 8,000 units are still unaccounted for.
Rutendo Kuwana from the WHO on October 13 had written to the DCGI seeking to know the progress with the investigation of the manufacturer of the four cough syrups the Sonipat-based Maiden Pharmaceuticals.
The committee to examine reports linking deaths of 66 children in The Gambia to four made-in-India cough syrups has observed the information shared by the World Health Organization is inadequate to determine aetiology.